Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 1

Third International Conference for Improving Use of Medicines (ICIUM2011):

Informed Strategies, Effective Policies, Lasting Solutions

Bibliotheca Alexandrina

April 10th-14th 2011

Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 2

WHO Eastern Mediterranean Region22 countries

Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 3

Introduction

The diversity in the region hinders any regional generalization.

Contexts are markedly different and so are the priorities.

A low income country – Pakistan – has a sizeable pharmaceutical industrial base.

A highest income country – Qatar – does not have any pharmaceutical company.

A lower middle income country – Jordan – has an FDA with a more than 400 staff.

An upper middle income country – Libya – has almost negligible regulatory capacity

Pharmaceutical Context & Priorities

Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 4

Classification of EMR countries by income(World bank 2009)

High-income Upper-middle-incomeBahrainKuwaitOmanQatarSaudi ArabiaUAE

LebanonLibya

Lower-middle-income Low-incomeDjiboutiEgyptIran, Islamic RepublicIraqJordanMoroccoPakistanPalestineSudanSyrian Arab RepublicTunisia

AfghanistanSomaliaYemen

Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 5

Analytical Matrix

W M S

Medicine Policy

Access

Quality - Regulation

Rational Use

Pharmaceutical Context & Priorities

Low Income

Countries

Lower M Income

Countries

Upper M Income

Countries

High Income

Countries

Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 6

Expenditure on medicinesfrom 9 NHA studies in the Region

■ 40% of total health expenditure is on medicines

■ Up to 30% of the budget of ministries of health is spent on medicines

■ Out-of-pocket expenditure is high

Egypt: 53% of all medicines are purchased directly by households

Morocco: 74%

Pharmaceutical Context & Priorities

Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 7

ICIUM Conferences

Goals:

•Assemble the state-of-the-art knowledge about ways to improve medicines use and health, especially for the most vulnerable populations

•Recommend evidence-based strategies for improving use at different levels in the health care system

•Identify ways to monitor and evaluate policy impacts

•Develop a research agenda to further knowledge about how to improve medicines use

Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 8

ICIUM conferences are unique

They focus on use of medicines in low and middle income countries

They are highly interactive

They produce actionable results

ICIUM 1997 and 2004 proceedings available at www.icium.org

Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 9

Partners Supporting ICIUM 2011

•International Network for Rational Use of Drugs

•World Health Organization•Eastern Mediterranean Regional Office •Department of Essential Medicines and Pharmaceutical Policies

•Harvard Medical School and Boston University School of Public Health: WHO Collaborating Center in Pharmaceutical Policy

•Karloniska Institute, Division of Global Health

•Management Sciences for Health, Strengthening Pharmaceutical Systems

•University of Alexandria

•Bibliotheca Alexandrina

Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 10

Conference Structure: Focus Areas

Conference discussions will focus on each on the following levels in health care systems where changes to improve medicines use take place:

Global

National

Institutional and

Individual (health care providers and consumers, including community systems)

Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 11

Conference Structure: Topic Track Objectives

•To cover major areas of clinical and programmatic interest related to pharmaceuticals in low and middle income countries

• To encourage cross-fertilization of ideas by having participants from different topic areas

Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 12

Conference Structure: Provisional Topic Tracks

Access (policy, regulation, governance)

HIV/AIDS, TB

Malaria

Maternal and child health (IMCI, pediatric medicines)

Chronic care (diabetes, hypertension, mental health, information technology for adherence)

Drug resistance (surveillance, containment strategies, drug development)

Economics, financing, insurance systems (cost, affordability, incentives, medicines coverage, policy options, impacts)

Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 13

ICIUM 2011 Participants

Each of the 500 or so participant of ICIUM2011 will be expected to play an active role in the conference.

Those with submitted abstracts are much more likely to be accepted.

ICIUM 2004 had 472 participants from 70 countries. There were 299 presentations and 326 posters.

Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 14

ICIUM 2011 Registration and Abstract Submission

Details of how to register and how to submit abstracts are posted on the ICIUM 2011 website www.icium.org

Abstracts must be submitted by 7 December 2010.

Each abstract will be peer reviewed. If improvements are needed authors will be mentored.

Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 15

Essential Medicines and Pharmaceutical Policies Unit Sept 2010– ICIUM 2011 16

Thank you

See you April 10th-14th 2011 in the Bibliotheca Alexandria

Watch www.icium.org for more information